The University of Chicago Header Logo

Connection

Ainhoa Arina to Clinical Trials, Phase III as Topic

Back to Details
This is a "connection" page, showing publications Ainhoa Arina has written about Clinical Trials, Phase III as Topic.
Ainhoa Arina
Connection Strength
0.016
Clinical Trials, Phase III as Topic
  1. [The immunotherapy potential of agonistic anti-CD137 (4-1BB) monoclonal antibodies for malignancies and chronic viral diseases]. An Sist Sanit Navar. 2006 Jan-Apr; 29(1):77-96.
    View in: PubMed
    Score: 0.016
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.